EP0687308A4 - Rekombinantes kapsidantigen des epstein-barr viruses welches nützlich in einer diagnostischen methode ist - Google Patents
Rekombinantes kapsidantigen des epstein-barr viruses welches nützlich in einer diagnostischen methode istInfo
- Publication number
- EP0687308A4 EP0687308A4 EP94910134A EP94910134A EP0687308A4 EP 0687308 A4 EP0687308 A4 EP 0687308A4 EP 94910134 A EP94910134 A EP 94910134A EP 94910134 A EP94910134 A EP 94910134A EP 0687308 A4 EP0687308 A4 EP 0687308A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- ebv
- viral capsid
- recombinant
- capsid antigen
- diagnostic method
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 108010026292 Epstein-Barr viral capsid antigen Proteins 0.000 title 1
- 238000002405 diagnostic procedure Methods 0.000 title 1
- 102000004169 proteins and genes Human genes 0.000 abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 238000002965 ELISA Methods 0.000 abstract 1
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 238000003556 assay Methods 0.000 abstract 1
- 210000000234 capsid Anatomy 0.000 abstract 1
- 238000001514 detection method Methods 0.000 abstract 1
- 210000005260 human cell Anatomy 0.000 abstract 1
- 238000010324 immunological assay Methods 0.000 abstract 1
- 230000035945 sensitivity Effects 0.000 abstract 1
- 241000701447 unidentified baculovirus Species 0.000 abstract 1
- 230000003612 virological effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K4/00—Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof
- C07K4/02—Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/06—Preparation of peptides or proteins produced by the hydrolysis of a peptide bond, e.g. hydrolysate products
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/14011—Baculoviridae
- C12N2710/14111—Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
- C12N2710/14141—Use of virus, viral particle or viral elements as a vector
- C12N2710/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16211—Lymphocryptovirus, e.g. human herpesvirus 4, Epstein-Barr Virus
- C12N2710/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Virology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US2195193A | 1993-02-23 | 1993-02-23 | |
| US21951 | 1993-02-23 | ||
| PCT/US1994/001775 WO1994019495A1 (en) | 1993-02-23 | 1994-02-23 | Recombinant epstein-barr viral capsid antigen useful in diagnostic method |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EP0687308A1 EP0687308A1 (de) | 1995-12-20 |
| EP0687308A4 true EP0687308A4 (de) | 1997-07-09 |
Family
ID=21807030
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP94910134A Withdrawn EP0687308A4 (de) | 1993-02-23 | 1994-02-23 | Rekombinantes kapsidantigen des epstein-barr viruses welches nützlich in einer diagnostischen methode ist |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP0687308A4 (de) |
| JP (1) | JPH08507681A (de) |
| KR (1) | KR960701218A (de) |
| AU (1) | AU674936B2 (de) |
| CA (1) | CA2150691A1 (de) |
| WO (1) | WO1994019495A1 (de) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2011127299A1 (en) * | 2010-04-09 | 2011-10-13 | The General Hospital Corporation | Methods for the treatment of autoimmune diseases |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3706233A1 (de) * | 1987-02-26 | 1988-09-08 | Behringwerke Ag | Immunogene fusionsproteine, die epstein-barr-virusproteine enthalten |
-
1994
- 1994-02-23 WO PCT/US1994/001775 patent/WO1994019495A1/en not_active Application Discontinuation
- 1994-02-23 CA CA002150691A patent/CA2150691A1/en not_active Abandoned
- 1994-02-23 EP EP94910134A patent/EP0687308A4/de not_active Withdrawn
- 1994-02-23 KR KR1019950703301A patent/KR960701218A/ko not_active Application Discontinuation
- 1994-02-23 JP JP6519171A patent/JPH08507681A/ja active Pending
- 1994-02-23 AU AU62693/94A patent/AU674936B2/en not_active Ceased
Non-Patent Citations (5)
| Title |
|---|
| BAYLIS,S.A. ET AL.: "High-level expression of the Epstein-Barr Virus Alkaline desoxyribonuclease using a recombinant baculovirus: application to the diagnosis of nasopharyngeal carcinoma", VIROLOGY, vol. 181, no. 1, March 1991 (1991-03-01), ORLANDO US, pages 390 - 394, XP000671825 * |
| FRAPPIER, L. & O'DONNELL M.: "Overproduction, purification, and characterization of EBNA1, the origin binding protein of Epstein-Barr virus", JOURNAL OF BIOLOGICAL CHEMISTRY (MICROFILMS), vol. 266, no. 12, 25 April 1991 (1991-04-25), MD US, pages 7819 - 7826, XP000673408 * |
| NUEBLING, C.M. ET AL.: "Expression of Epstein-Barr virus membrane antigen gp350/220 in E. coli and in insect cells", VIROLOGY, vol. 191, no. 11, November 1992 (1992-11-01), ORLANDO US, pages 443 - 447, XP000673411 * |
| SCHUBACH, W.H. ET AL.: "Expression of Epstein-Barr virus Nuclear Antigen 2 in insect cells from a baculovirus vector", VIROLOGY, vol. 185, no. 1, November 1991 (1991-11-01), ORLANDO US, pages 428 - 431, XP000671826 * |
| See also references of WO9419495A1 * |
Also Published As
| Publication number | Publication date |
|---|---|
| EP0687308A1 (de) | 1995-12-20 |
| AU6269394A (en) | 1994-09-14 |
| WO1994019495A1 (en) | 1994-09-01 |
| JPH08507681A (ja) | 1996-08-20 |
| KR960701218A (ko) | 1996-02-24 |
| CA2150691A1 (en) | 1994-09-01 |
| AU674936B2 (en) | 1997-01-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Luka et al. | A sensitive enzyme-linked immunosorbent assay (ELISA) against the major EBV-associated antigens. I. Correlation between ELISA and immunofluorescence titers using purified antigens | |
| GB8404368D0 (en) | Monoclonal antibodies to human cytomegalovirus | |
| ZA853025B (en) | Isolation of proteins of htlv-iii,serological detection of antibodies to htlv-iii in sera of patients with aids and pre-aids conditions,and detection of htlv-iii infection by immuno-assays using htlv-iii and its proteins | |
| Vornhagen et al. | Early serodiagnosis of acute human cytomegalovirus infection by enzyme-linked immunosorbent assay using recombinant antigens | |
| EP0284587A3 (de) | Synthetische Peptid-Antigene für den Nachweis von HIV-1-Infektionen | |
| AU8849391A (en) | An augmented western blot format and immunoassay for detection of viral antibodies | |
| Nielsen et al. | An enzyme labelled nuclear antigen immunoassay for detection of cytomegalovirus IgM antibodies in human serum: specific and non‐specific reactions | |
| AU7345487A (en) | Layered immunoassay using antibodies bound to transport particles to determine the presence of an antigen | |
| DK187286A (da) | Herpes-virus-specifikke immunologiske materialer og metoder | |
| EP0248534A3 (de) | Verfahren zum Nachweis einer AIDS-Virus-Infektion | |
| AU735981B2 (en) | Peptide reagent for the detection of human cytomegalovirus (CMV) | |
| WO1997031117A3 (en) | A human cytomegalovirus combined antigen and its use | |
| WO1995016040A3 (en) | Immunofluorescence assay for the detection of antibodies using recombinant antigens in insoluble form | |
| AU7737091A (en) | Immunodiagnostic assay for rheumatoid arthritis | |
| IE860315L (en) | Detecting htlv-iii neutralising antibodies | |
| EP0687308A4 (de) | Rekombinantes kapsidantigen des epstein-barr viruses welches nützlich in einer diagnostischen methode ist | |
| EP0504388A4 (en) | Varicella-zoster virus antigen | |
| CA2120342A1 (en) | Epstein-barr virus peptides and antibodies against these peptides | |
| EP0238971A3 (de) | Einem Lymphokin entgegenstehender Antikörper | |
| EP0754755A3 (de) | Rekombinante autologe Fusionsproteine des Epstein-Barr-Virus, diese enthaltende Testkits und Verfahren zum Nachweis von Epstein-Barr-Virus-spezifischen Antikörpern | |
| Spiezia et al. | Prevalence of specific antibodies to herpes simplex virus type 2 as revealed by an enzyme-linked immunoassay and Western blot analysis | |
| GB2323360A (en) | Peptide structures for use in detecting herpes simplex virus type 2 | |
| Silvestri et al. | Fine specificity and neutralizing activity of human serum antibodies directed to the major antigenic region on gp 116 of human cytomegalovirus | |
| Zal et al. | Epitope mapping of mouse monoclonal antibodies to the ppUL83 lower matrix phosphoprotein of human cytomegalovirus | |
| IT1250367B (it) | Materiale proteico legante anticorpi contro il citomegalovirus umano e reagenti diagnostici derivati da tale materiale proteico. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| 17P | Request for examination filed |
Effective date: 19950712 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE |
|
| RHK1 | Main classification (correction) |
Ipc: C12N 15/86 |
|
| A4 | Supplementary search report drawn up and despatched |
Effective date: 19970523 |
|
| AK | Designated contracting states |
Kind code of ref document: A4 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
| 18D | Application deemed to be withdrawn |
Effective date: 19990901 |